Evidence map›Paper›PMID 25763797›Full record

ArticleBMJ open2014

Rationale and design of the Pan African Pulmonary hypertension Cohort (PAPUCO) study: implementing a contemporary registry on pulmonary hypertension in Africa.

Friedrich Thienemann, Anastase Dzudie, Ana O Mocumbi, Lori Blauwet, Mahmoud U Sani, Kamilu M Karaye, Okechukwu S Ogah, Irina Mbanze, Amam Mbakwem, Patience Udo and 6 more

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Pulmonary vascular disease in Africa: Lessons from registries.Global cardiology science & practice · 2020
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 11 institutions in 7 countries.

Friedrich ThienemannClinical Infectious Diseases Research Initiative, Institute of Infectious Diseases and Molecular Medicine, Faculty of Health Science, University of Cape Town, Cape Town, South Africa.
Anastase DzudieDepartment of Medicine, University of Cape Town, Cape Town, South Africa.
Ana O MocumbiInstituto Nacional de Saúde, Maputo, Mozambique.
Lori BlauwetDivision of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA.
Mahmoud U SaniDepartment of Medicine, Bayero University and Aminu Kano Teaching Hospital, Kano, Nigeria.
Kamilu M KarayeDepartment of Medicine, Bayero University and Aminu Kano Teaching Hospital, Kano, Nigeria.
Okechukwu S OgahDepartment of Medicine, University College Hospital Ibadan, Ibadan, Nigeria.
Irina MbanzeFaculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique.
Amam MbakwemDepartment of Medicine, College of Medicine, University of Lagos, Lagos, Nigeria.
Patience UdoDepartment of Medicine, University of Uyo Teaching Hospital, Uyo, Nigeria.
Kemi TibazarwaHatter Institute for Cardiovascular Research in Africa, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Ahmed S IbrahimAlzaiem Alazhary University, Alshaab Teaching Hospital, Khartoum, Sudan.
Rosie BurtonKhayelitsha District Hospital, Khayelitsha, South Africa.
Albertino DamascenoFaculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique.
Simon StewartDepartment of Preventative Cardiology, Baker Heart Research Institute, Melbourne, Australia.
Karen SliwaDepartment of Medicine, University of Cape Town, Cape Town, South Africa.
University of Cape Town · ZAEduardo Mondlane University · MZAlzaiem Alazhari University · SDAminu Kano Teaching Hospital · NGBayero University Kano · NGFederal Ministry of Health · NGInstituto Nacional de Saúde · MZMayo Clinic · USThe Heart Research Institute · AUUniversity of Lagos · NGUniversity of Uyo Teaching Hospital · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPulmonary hypertension (PH) is a devastating, progressive disease with increasingly debilitating symptoms and usually shortened overall life expectancy due to a narrowing of the pulmonary vasculature and consecutive right heart failure. Little is known about PH in Africa, but limited reports suggest that PH is more prevalent in Africa compared with developed countries due to the high prevalence of risk factors in the region. METHODS AND ANALYSIS: A multinational multicentre registry-type cohort study was established and tailored to resource-constraint settings to describe disease presentation, disease severity and aetiologies of PH, comorbidities, diagnostic and therapeutic management, and the natural course of PH in Africa. PH will be diagnosed by specialist cardiologists using echocardiography (right ventricular systolic pressure >35 mm Hg, absence of pulmonary stenosis and acute right heart failure), usually accompanied by shortness of breath, fatigue, peripheral oedema and other cardiovascular symptoms, ECG and chest X-ray changes in keeping with PH as per guidelines (European Society of Cardiology and European Respiratory Society (ESC/ERS) guidelines). Additional investigations such as a CT scan, a ventilation/perfusion scan or right heart catheterisation will be performed at the discretion of the treating physician. Functional tests include a 6 min walk test and the Karnofsky Performance Score. The WHO classification system for PH will be applied to describe the different aetiologies of PH. Several substudies have been implemented within the registry to investigate specific types of PH and their outcome at up to 24 months. Data will be analysed by an independent institution following a data analyse plan. ETHICS AND DISSEMINATION: All local ethics committees of the participating centres approved the protocol. The data will be disseminated through peer-reviewed journals at national and international conferences and public events at local care providers.

Indexed as

Cohort StudiesHypertension, PulmonaryRegistriesResearch DesignAfricaHumansMulticenter Studies as TopicVentricular Dysfunction, RightAfricaHIV/AIDSpulmonary hypertension

Identifiers

PMID25763797
PMCPMC4202005
OpenAlexW2054577648

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.